Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2017 · 10-Q
Revenue$70.62M$70.62M−2.4% vs Q1 2016 Net Income$6.15M$6.15M+44.2% vs Q1 2016 EPS Diluted$0.51$0.51+41.7% vs Q1 2016 Gross Profit$52,892,000−0.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$6,683,000−12.8% Free Cash Flowderived$6,213,000−18.1% Margins · derivedGross margin74.9%+1.4 pt vs Q1 2016
Operating margin12.2%+3.5 pt vs Q1 2016
Net margin8.7%+2.8 pt vs Q1 2016
ended Mar 31, 2017 · filed May 10, 2017 · 40 d after period end